Gratwohl, AloisAloisGratwohlPasquini, MarceloMarceloPasquiniAljurf, MahmoudMahmoudAljurfAtsuta, YoshikoYoshikoAtsutaBaldomero, HelenHelenBaldomeroFoeken, LydiaLydiaFoekenGratwοhl, ΜichaelΜichaelGratwοhlBouzas, Luis FernandoLuis FernandoBouzasConfer, DennisDennisConferFrauendorfer, KarlKarlFrauendorferGluckman, ElianeElianeGluckmanGreinix, HildegardHildegardGreinixHorowitz, MaryMaryHorowitzIida, MinakoMinakoIidaLipton, JeffJeffLiptonMadrigal, AlejandroAlejandroMadrigalMohty, MohamadMohamadMohtyNoel, LucLucNoelNovitzky, NicolasNicolasNovitzkyNunez, JoséJoséNunezOudshoorn, MachteldMachteldOudshoornPassweg, JakobJakobPasswegvan Rood, JonJonvan RoodSzer, JeffJeffSzerBlume, KarlKarlBlumeAppelbaum, FredericFredericAppelbaumKodera, YoshihisaYoshihisaKoderaNiederwieser, DietgerDietgerNiederwieser2023-04-132023-04-132015-03https://www.alexandria.unisg.ch/handle/20.500.14171/10670810.1016/S2352-3026(15)00028-9Our findings show achievements and high unmet needs and give guidance for decisions; to grant access for patients, to provide a donor infrastructure, and to limit overuse by defining risk and region adapted indications for HSCT as an efficient and cost-effective approach for life-threatening, potentially curable diseases.enjournal article